COPD Trial
Chronic Obstructive Pulmonary Disease (COPD)
Not SpecifiedActive
Key Facts
Indication
Chronic Obstructive Pulmonary Disease (COPD)
Phase
Not Specified
Status
Active
Company
About Well Pharma Medical Research
Well Pharma Medical Research is a US-based clinical research site organization providing trial execution services for pharmaceutical and biotech sponsors. Founded and led by Dr. Eddie Armas, the company operates two dedicated units for early and late-phase trials, supported by an on-site CLIA-certified lab, secure pharmacy, and proficiency with major electronic data capture systems. Its business model is service-based, generating revenue from conducting clinical trials for external partners across indications like dermatology, respiratory, and metabolic diseases. The company's outlook is tied to the robust clinical trial activity in South Florida and its established investigator network.
View full company profileTherapeutic Areas
Other Chronic Obstructive Pulmonary Disease (COPD) Drugs
| Drug | Company | Phase |
|---|---|---|
| PUR0200 | Pulmatrix | Preclinical |
| Dupixent (dupilumab) | Regeneron | Phase 3 |
| AN01 | AirNexis Therapeutics | Phase 2 |
| COPD Diagnostic/Prognostic Test | Oxford Cancer Analytics | Pre-clinical |
| SMS Cell Therapy | SMSbiotech | Phase 1b |
| dNerva Lung Denervation System / Targeted Lung Denervation (TLD) | Nuvaira | Phase 3 |
| LBP for COPD | Alveolus Bio | Preclinical |
| AstraZeneca Collaboration Programs | Ethris | Discovery/Pre-clinical |
| COPD Phenotyping & Progression Biomarkers | Thirona | Commercial/Validation |
| TEZSPIRE (tezepelumab) | Amgen | Phase 3 |
| Verekitug (UPB-101) | Upstream Bio | Phase 2 |